Clay Brian Ritchey - 23 Oct 2026 Form 4 Insider Report for Definitive Healthcare Corp. (DH)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Oct 2026, 16:05:05 UTC
Prior SEC filing
16 Sep 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jonathan Paris, Attorney-in-Fact
Filing notes and source

Key filing fact

Clay Brian Ritchey filed Form 4 for Definitive Healthcare Corp. (DH) on 27 Oct 2026.

Key facts

  • This page summarizes Clay Brian Ritchey's Form 4 filing for Definitive Healthcare Corp. (DH).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 27 Oct 2026, 16:05.

Change

  • Previous filing in this sequence was filed on 16 Sep 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002153657 Primary reporting owner

Ritchey Clay Brian

Relationship
Chief Executive Officer, Director
Address
C/O DEFINITIVE HEALTHCARE CORP., 492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM
Signature
/s/ Jonathan Paris, Attorney-in-Fact
Signature date
27 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DH transaction

Class A Common Stock

Award

Transaction value
Shares
+2,626,263
Change %
Price
$0.000000*
Shares after
2,626,263
Date
23 Oct 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001, with 25% of the RSUs vesting on September 8, 2027, followed by vesting of 6.25% every three months thereafter over the subsequent three years, subject to the Reporting Person's continued service with the Issuer through each such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .